APA (7th ed.) Citation

Planchard, D., Reinmuth, N., Orlov, S., Fischer, J. R., Sugawara, S., Mandziuk, S., . . . D.Planchard, N. (2020). ARCTIC: Durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer. Annals of Oncology, 31(5), 609.

Chicago Style (17th ed.) Citation

Planchard, D., et al. "ARCTIC: Durvalumab with or Without Tremelimumab as Third-line or Later Treatment of Metastatic Non-small-cell Lung Cancer." Annals of Oncology 31, no. 5 (2020): 609.

MLA (9th ed.) Citation

Planchard, D., et al. "ARCTIC: Durvalumab with or Without Tremelimumab as Third-line or Later Treatment of Metastatic Non-small-cell Lung Cancer." Annals of Oncology, vol. 31, no. 5, 2020, p. 609.